Howard Alvin D 4
4 · Foamix Pharmaceuticals Ltd. · Filed Jan 24, 2018
Insider Transaction Report
Form 4
Howard Alvin D
VP Regulatory
Transactions
- Tax Payment
Ordinary Shares
2018-01-02$5.98/sh−924$5,526→ 34,991 total - Exercise/Conversion
Ordinary Shares
2018-01-01+2,288→ 35,915 total - Exercise/Conversion
Restricted Share Units
2018-01-01−2,288→ 0 totalExercise: $0.00→ Ordinary Shares (2,288 underlying)
Footnotes (5)
- [F1]This security represents restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.
- [F2]The issuer's method of reporting restricted share units has been revised to report such grants in Table I rather than as previously reported in Table II. Accordingly, this amount includes (i) 18,390 ordinary shares previously reported in Table I of the reporting person's Form 3, (ii) 2,288 ordinary shares underlying restricted share units that vested on January 1, 2018 and (ii) 15,237 ordinary shares subject to unvested restricted share units that were previously reported in Table II of the reporting person's Form 3 as a derivative security.
- [F3]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of restricted share units.
- [F4]The ordinary shares underlying this restricted share unit award vest over a period of four years (25% on January 1, 2018 and 6.25% every three months thereafter) ending January 1, 2021.
- [F5]This class of restricted share units is included in Column 5 of Table I above.